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Abstract
The objective was to investigate the hypothesis
that environmental exposure to cadmium may
affect calcium metabolism in the population at
large. The 1987 participants (965 men and 1022
women), from 20 to 80 years old, constituted a
random sample of the population of four
Belgian districts. The urinary excretion of
cadmium, a measure of lifetime exposure,
averaged 9-3 nmol/24 h in men (range 0 4-324
nmol/24 h) and 7-1 nmol/24 h (range 0-1-71
nmol/24 h) in women. Serum alkaline phos-
phatase activity and the urinary excretion of
calcium correlated significantly and positively
with urinary cadmium excretion in both men
and women, and serum total calcium con-
centration negatively with urinary cadmium
excretion in men only. The regression
coefficients obtained after adjustment for
significant covariates indicated that when
urinary cadmium excretion increased twofold,
serum alkaline phosphatase activity and urin-
ary calcium excretion rose by 3-4% and 0 25
mmoll24 h respectively, whereas in men serum
total calcium concentration fell by 6 umolIl.
After adjustment for significant covariates the
relation between serum total calcium concen-
tration and urinary cadmium excretion was
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not significant in women. The findings suggest
that even at environmental exposure levels
calcium metabolism is gradually affected,
as cadmium accumulates in the body. The
morbidity associated with this phenomenon in
industrialised countries remains presently
unknown and requires further investigation.
The exposure of human populations to cadmium
via the environment is raising much concern, as
cadmium is a heavy metal with high toxicity and
accumulates in the body.'
Cadmium interferes with the metabolism of
vitamin D, calcium, and collagen, and its accumula-
tion may lead to osteomalacia and osteoporosis.'2
These effects are usually considered to be late mani-
festations of severe cadmium poisoning, and have
been seen in exposed workers and in malnourished
subjects.'" The quantitative dose-response relation
for the effects of cadmium on calcium and bone
metabolism, however, remains presently unknown.
The present report, part of a cross sectional study
on the effects of cadmium on public health,"7
investigated whether environmental exposure to




As described elsewhere,"7 the 2327 subjects (age
range from 20 to 79) constituted a random sample of
the population of four Belgian districts selected to
provide a wide range of environmental exposure to
cadmium. Subjects were excluded from the present
analysis when not all relevant measurements were
available (n = 248), when 24 hour urine samples
were judged under or over collected by previously
published criteria (n = 44),8 or when either
occupational exposure to heavy metals (n = 41) or
smoking habits (n = 7) could not be ascertained
from a self administered questionnaire.
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FIELD WORK
All participants were visited at home on several
occasions. Body weight was determined with indoor
clothing. A self administered questionnaire was used
to inquire about the subjects' medical history, their
current and past occupations, smoking habits, alco-
hol consumption, intake of medicines, and about the
menstrual state of female participants. The subjects
collected a 24 hour urine sample in a wide neck metal
free polyethylene container. At a separate home visit,
usually within two weeks of the urine collection,
20 ml of venous blood were drawn.
BIOCHEMICAL MEASUREMENTS
The biochemical techniques and procedures for
quality control have been described in detail else-
where.' Alkaline phosphatase activity was deter-
mined on a COBAS-BIO centrifugal analyser (Roche
Diagnostics).9 Serum and urinary calcium concen-
trations were measured by compleximetry,'° and
urinary cadmium by electrothermal atomic absorp-
tion spectrometry using a stabilised temperature
platform furnace and Zeeman background correc-
tion.5
STATISTICAL ANALYSIS
For statistical analysis the SAS software package was
used." Where appropriate a logarithmic transforma-
tion was applied to normalise the distribution of the
biochemical measurements. Statistical methods
included Student's t test, analysis of covariance, and
single and multiple linear regression.
Significant covariates were traced by stepwise
regression. Age adjustments included both a linear
and quadratic term of age.
Results
CHARACTERISTICS OF THE PARTICIPANTS
The present analysis included 965 men and 1022
*women. Table 1 summarises their anthropometric
characteristics and biochemical results.
Current smoking was reported by 471 men
(median tobacco consumption equivalent to 18
cigarettes a day), and 354 women (median 20 ciga-
rettes a day), and regular alcohol intake by 357 men
(median alcohol consumption 20 g/day) and 142
women (median 16 g/day). Fifty two men and 122
women were on treatment with diuretics and 210
women took the contraceptive pill. The study
population included 462 postmenopausal women.
SERUM ALKALINE PHOSPHATASE ACTIVITY
Serum alkaline phosphatase activity (SAPA) was
positively associated with urinary cadmium excre-
tion (UCd) in both sexes (figure). The single correla-
tion coefficient was 0- 10 (p = 0 003) in men and 0 30
(p < 0001) in women.
Age and body mass index combined explained 3%
(p < 0-001) of the variance of SAPA in men, and
21% (p < 0-001) in women (table 2). The SAPA was
independently related to y-glutamyltranspeptidase
activity, to being a regular consumer of alcoholic
beverages, and to the daily alcohol consumption
(g/day) (table 2). These three covariates combined
explained 5% (p < 0-001) ofthe variance ofSAPA in
men, and 8% of the variance (p < 0 001) in women.
After adjustment for significant covariates SAPA
remained positively associated with UCd in men
(partial R2 = 0-017; p < 0-001) and women (partial
R' = 0-004; p = 0-02). The slopes of these relations
(table 2) indicated that a twofold increase in UCd was
accompanied by a rise in SAPA by around 3-4%
(95% confidence interval from 2 to 6% in men, and
from 1 to 5% in women).
SERUM TOTAL CALCIUM CONCENTRATION
Serum total calcium concentration (STCa) was
negatively associated with UCd in men (figure); the
Table 1 Characteristics of the participants
Men (n = 965) Women (n = 1022)
Clinical measurements:
Age (y) 48-4 (15-9) 47-6 (16-4)
Body mass index (kg/m2) 25-5 (3 6) 25-3 (5-1)
Serum measurements:
Alkaline phosphatase (U/l)t 120 (33-857) 109 (22-527)***
y-GT (U/I)t 14 (2-252) 10 (2-335)***
Total calcium (mmol/l) 2-37 (0-10) 2-36 (0-11)
Magnesium (mmol/l) 1-01 (0 07) 1-00 (0-08)
Urinary measurements:
Volume (1/24 h) 1-65 (0 70) 1-67 (0 74)
Cadmium (nmol/24 h)t 9 3 (04-324) 7-1 (0-1-70-8)***
Calcium (mmol/24 h) 4-86 (2-68) 3-95 (2 20)***
Creatinine (mmol/24 h) 15-4 (4 0) 10-5 (2-7)***
Values are means (SD). For logarithmically transformed distributions (t) the geometric mean and range are presented.
***p < 0-001 for difference between men and women.
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Urinary cadmium excretion (nmol/24h)
Serum alkaline phosphatase activity (top panel), serum total
calcium concentration (middle panel), and urinary excretion
of calcium (bottom panel) in quintiles of the body burden of
cadmium (estimatedfrom the urinary excretion of cadmium).
The analyses were performed in men and women separately.
correlation coefficient was -0-17 (p < 0-001). The
single correlation coefficient between STCa andUCd
in women was positive (r = 0-06; p = 0-05).
After adjustment for significant covariates (table 2),
an independent and negative correlation was found
between STCa and UCd in men (partial R2 = 0 01;
p < 0 001). The slope of this relation (table 2)
indicated that a twofold rise in UCd was associated
with a decrease in STCa of 6 jumol/l (95% confidence
interval from 3 to 12 ymol/l). In women the partial
correlation between STCa and UCd (r = 0-004),
when adjusted for significant covariates, was far from
significant.
CALCIURIA
Urinary calcium excretion (UCa) tended to be
positively associated with UCd in both sexes (figure).
The single correlation coefficient was 0 05 (p = 0 1)
in men and 0-10 (p = 0 001) in women.
After adjustment for significant covariates (table 2),
an independent and positive correlation was found
between UCa and UCd in the two sexes (partial
R' = 0 01; p < 0001 in both men and women). The
slopes of these relations (table 2) indicated that a
twofold rise in UCd was associated with an increase
in UCa by approximately 0-25 mmol/24 h (95%
confidence interval from 0 13 to 0-45 mmol/24 h in
men, and from 0 10 to 0 39 mmol/24 h in women).
EXPOSURE AT WORK
Possible exposure to heavy metals at work was
reported by 304 men; UCd in these subjects averaged
13-7 nmol/24 h (range: 0-7-324 nmol/24 h) and was
higher (p < 0 001) than in the other men (mean:
7-9 nmol/24 h; range: 0 4-34 nmol/24 h). Excluding
men with exposure to cadmium at work, however,
did not materially alter the size of the partial regres-
sion coefficients for UCd shown in table 2. For the
relation with SAPA the partial regression coefficient
was 0-048 + 0-018 log U/l/log nmol/24 h
(p = 0 01); for STCa -0 011 + 0-015 mmol/log
nmol/24 h; and for UCa 1 313 + 0-358 mmol/nmol
(p = 0 003).
Discussion
In the present population study, three indices of
calcium metabolism were related to the urinary
excretion of cadmium, a reliable index of lifetime
exposure to cadmium.' The direction of the correla-
tions was positive for SAPA and for UCa in both
sexes, and negative for STCa in men.
Liver and bone isoenzymes constitute the princi-
pal fractions of alkaline phosphatase activity in the
serum of normal adults.'2"3 Serum alkaline phos-
phatase activity increases with age, mainly due to an
increased release of the enzyme from the hepatocytes
beyond age 50.' 1-6 When SAPA phosphatase is
high, normal serum y-glutamyltranspeptidase
activity suggests an involvement of bone tissue. In
the present analysis the effects of ageing and liver
dysfunction on alkaline phosphatase activity were
accounted for. Adjustments for liver dysfunction
were effected based on serum y-glutamyltranspep-
tidase activity, reported alcohol intake, and the
amount of alcohol consumed each day (g/day).
Serum total calcium concentration and the UCa
decrease with advancing age.'7 Diuretics increase
STCa, lower calciuria, and improve calcium
balance.'"2' Sex steroids, including oral contracep-
tives, stimulate bone formation and decrease SCa and
UCa, whereas withdrawal of sex hormones after the
menopause leads to opposite effects."'4 The effects of
age, diuretics, the contraceptive pill, and menopause
on STCa and calciuria were confirmed in the present
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Table 2 Multiple regression analysis
Men Women
SAPA STCa UCa SAPA STCa UCa
R2 00067 0 099 0-142 0 284 0-045 0 095
Intercept 2 164 2 411 -3-296 1 756 2 363 -3 168
Regression coefficients
Log urinary cadmium 0 056 -0-021 0 972 0 035 NS 0 840
FAge -78E-4 -19E-4 0077 -13E-4 61E-5 0 076LAge2 78E-8 94E-8 -1 3E-4 40E-6 - 17E-6 - 98E-5
Body mass index 24E-4 27E4 0-113 29E4 NS NS
Log serum y-GT 0-094 - - 0 145 -
[Drinking alcohol* -0-013 - - -0-029 -Alcohol intake (g/day) -48E-5 - - -36E-5 - -
[Serum calcium - - 0 402 - - 1 697Serum magnesium - - 2-934 - - 1 438
On diuretics* NS 0-037 -1-402 NS 0 037 -1-052
On contraceptive pill* - - - NS -0 031 -0-321
Being menopausal* - - - NS 0 046 NS
Only significant regression coefficients are presented (exponent of base 10 given, where appropriate); NS = non-significant; - = not
considered for entry into the model. Bracketed covariates were tested simultaneously for entry into the model.
SAPA = Serum alkaline phosphatase activity (logarithmically transformed); STCa = serum total calcium concentration; UCa = urinary
calcium excretion; GT = y-glutamyltranspeptidase activity.
*Coded 0 or 1 for condition being present or absent.
population; they were taken into account when the
relations between STCa and UCa and the body
burden of cadmium were investigated (table 2).
Acute hypermagnesaemia probably inhibits the
secretion of parathyroid hormone2" and magnesium
ions compete with calcium for reabsorption in the
loop of Henle.26 These mechanisms2526 may explain
why, in our study, a positive relation was found
between serum magnesium concentration and UCa
(table 2).
Interference with the metabolism of calcium is
usually considered to be a late manifestation ofsevere
cadmium intoxication. By contrast with this long
held belief, the associations shown in the figure and
the fit obtained with linear regression (table 2) suggest
that no threshold exists, and that the effects on
calcium metabolism develop gradually, as during life
cadmium accumulates in the body. Indeed, the
slopes ofthe independent relations reported in table 2
show that when UCd doubles SAPA and UCa rise in
both sexes by 3-4% and 025 mmol/24 h respec-
tively, whereas SCa in men falls by 6 pmol/l. These
effects on calcium metabolism may be due to renal
tubular dysfunction, or the development of vitamin
D resistance, or both.' 2
Whether the small metabolic effects seen in the
present study also lead to clinically manifest mor-
bidity in the population at large remains to be
elucidated. Among the Shipham residents27 and
among British workers28 exposure to cadmium was
not associated with excess mortality from fractures.
On the other hand, bone lesions have been
experimentally induced by cadmium in several
species of laboratory animals, in whom the combined
effects ofcadmium, poor nutrition, and low vitaminD
intake proved to be particularly harmful.2 The results
from these animal studies are supported by
epidemiological findings. Indeed, about 50 cases of
osteomalacia or osteoporosis have been seen among
cadmium exposed labourers world wide,2 and some
150 Japanese subjects have developed bone lesions as
a consequence of severe exposure to cadmium via the
environment.2 The incidence of these bone effects
appears to have peaked 30 to 40 years ago when
dietary intake of nutrients was often deficient in
countries with reported cases. In developed coun-
tries and in modem times, however, many subjects
suffer from decalcification ofthe skeleton as a result of
ageing, or hormonal or nutritional deficiencies, or
both."7 It is therefore conceivable that in these
subjects, who are at higher risk of skeletal deforma-
tion, environmental exposure to cadmium through
its effecton calcium metabolism may precipitate overt
bone disease and contribute to osteoporosis and its
consequences-for example, lower forearm frac-
tures, compression fractures ofthe vertebrae, and hip
fractures. As the UCas found in our present study
were comparable with those of other industrialised
countries,' 3 this hypothesis is an important public
health issue and requires further investigation.
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1 mmol = 40 1 mg
lmmol = 1131mg
1 ,umol = 207 1 ig
1 mmol = 24 3 mg
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